FDA Approves Use of AFLURIA® Influenza Vaccine with PharmaJet’s Needle-Free Injector

August 19th, 2014 PharmaJet® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA® (Influenza Vaccine) today announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis® 0.5mL Needle-Free Jet Injector for delivery of AFLURIA in individuals aged 18 to 64 years. This is the first needle-free delivery …

If you’re allergic to dust mites (and chances are you are) help may be on the way

Researchers Create Vaccine for Dust-Mite Allergies

If you’re allergic to dust mites (and chances are you are) help may be on the way Researchers at the University of Iowa have developed a vaccine that can combat dust-mite allergies by changing the body’s immune response. In animal tests, the vaccine lowered lung inflammation by 83 percent, according to the paper published in the AAPS (American Association of …